Strategies for Supporting Early Diagnosis and Implementation of Amyloid-Targeting Therapies in Alzheimer Disease : Episode 15
Opinion
Video
Key Barriers in Managing Patients With Mild Cognitive Impairment Using Amyloid-Targeting Therapies
Panelists discuss how managing patients with mild cognitive impairment using amyloid-targeting therapies faces significant barriers including limited healthcare infrastructure for complex diagnostic testing and monitoring, insufficient insurance coverage and high out-of-pocket costs, challenges in patient selection and risk stratification, logistical hurdles of regular infusions and imaging, shortage of specialists in many regions, and the need for comprehensive patient education about realistic treatment expectations.
Video content above is prompted by the following:
Related Videos
Related Content
